Benitec Biopharma (BNTC) Stock Price

Benitec Biopharma Price

Frankfurt·CLOSED
11.71USD-0.15 (-1.27 %)
Market closed

Revenue at Benitec Biopharma has contracted by 18.9% per year over the past 17 years to 80,000.00 USD. Benitec Biopharma's net margin stands at -24,450.0%, down from 24.7% several years earlier. Benitec Biopharma currently offers a dividend yield of about 0.03%. Analysts set a median price target of 24.48 USD, implying 109.1% above the current price. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus. Over the past year Benitec Biopharma shares have gained 0.5%. The stock trades about 16% above its 52-week low.

Benitec Biopharma stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Benitec Biopharma over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Benitec Biopharma stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Benitec Biopharma's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Benitec Biopharma Stock Price History
DateBenitec Biopharma Price
7/31/202611.71 USD
7/30/202611.86 USD
7/29/202611.84 USD
7/27/202611.56 USD
7/23/202611.44 USD
7/22/202611.44 USD
7/21/202611.89 USD
7/20/202611.97 USD
7/17/202612.78 USD
7/16/202612.66 USD
7/15/202613.02 USD
7/14/202612.98 USD
7/13/202613.22 USD
7/10/202613.42 USD
7/9/202613.48 USD
7/8/202613.64 USD
7/7/202613.44 USD
7/6/202613.33 USD
7/2/202613.22 USD
7/1/202612.69 USD
6/30/202613.38 USD
6/29/202612.70 USD
6/26/202612.37 USD
6/25/202613.00 USD
6/24/202613.63 USD
6/23/202612.88 USD
6/22/202612.30 USD
6/18/202612.15 USD
6/17/202611.80 USD
6/16/202611.10 USD
6/15/202611.33 USD
6/12/202611.18 USD
6/11/202610.80 USD
6/10/202610.39 USD
6/5/202610.55 USD
6/4/202611.05 USD
6/3/202610.40 USD
6/2/202610.58 USD
6/1/202610.82 USD
5/29/202611.56 USD
5/28/202611.56 USD
5/27/202611.60 USD
5/26/202611.45 USD
5/22/202611.23 USD
5/21/202611.36 USD
5/20/202610.99 USD
5/19/202610.72 USD
5/18/202610.89 USD
5/15/202611.49 USD
5/13/202611.65 USD
5/4/202612.18 USD
5/1/202611.95 USD
4/30/202612.05 USD
4/29/202612.15 USD
4/28/202612.17 USD
4/27/202612.61 USD
4/24/202612.37 USD
4/23/202612.70 USD
4/22/202612.96 USD
4/21/202613.18 USD
4/20/202613.99 USD
4/17/202614.08 USD
4/16/202613.46 USD
4/15/202613.60 USD
4/14/202613.25 USD
4/13/202612.00 USD
4/10/202611.42 USD
4/9/202611.01 USD
4/8/202611.06 USD
4/7/202610.91 USD
4/6/202610.99 USD
4/2/202610.92 USD
4/1/202610.92 USD
3/31/202610.97 USD
3/30/202610.65 USD
3/29/202610.06 USD
3/27/202610.27 USD
3/26/202610.27 USD
3/25/202610.81 USD
3/24/202610.84 USD
3/23/202610.70 USD
3/22/202611.19 USD
3/20/202610.98 USD
3/19/202610.98 USD
3/18/202611.50 USD
3/17/202611.68 USD
3/16/202611.75 USD
3/15/202612.01 USD
3/13/202611.75 USD
3/12/202611.75 USD
3/11/202612.12 USD
3/10/202612.28 USD
3/9/202612.27 USD
3/8/202612.55 USD
3/6/202611.34 USD
3/5/202611.34 USD
3/4/202610.60 USD
3/3/202610.91 USD
3/2/202610.46 USD
3/1/202610.83 USD
2/27/202610.90 USD
2/26/202610.90 USD
2/25/202611.19 USD
2/24/202611.00 USD
2/23/202611.12 USD
2/22/202610.72 USD
2/20/202610.64 USD
2/19/202610.64 USD
2/18/202610.84 USD
2/17/202610.57 USD
2/16/202610.36 USD
2/13/202610.38 USD
2/12/202610.38 USD
2/11/202611.34 USD
2/10/202611.65 USD
2/9/202611.70 USD
2/8/202611.79 USD
2/6/202612.12 USD
2/5/202612.12 USD
2/4/202611.65 USD
2/3/202612.41 USD
2/2/202612.59 USD
2/1/202612.46 USD
1/30/202612.18 USD
1/29/202612.18 USD
1/28/202612.61 USD
1/27/202612.08 USD
1/26/202612.55 USD
1/25/202612.22 USD
1/23/202612.48 USD
1/22/202612.48 USD
1/21/202612.83 USD
1/20/202612.12 USD
1/19/202611.63 USD
1/16/202611.68 USD
1/15/202611.68 USD
1/14/202611.71 USD
1/13/202612.13 USD
1/12/202612.30 USD
1/11/202612.14 USD
1/9/202611.84 USD
1/8/202611.84 USD
1/7/202612.18 USD
1/6/202612.14 USD
1/5/202611.99 USD
1/4/202611.89 USD
1/2/202612.59 USD
1/1/202612.59 USD
12/31/202513.47 USD
12/30/202513.47 USD
12/29/202513.93 USD
12/28/202513.49 USD
12/26/202513.10 USD
12/25/202513.10 USD
12/24/202513.05 USD
12/23/202513.05 USD
12/22/202512.96 USD
12/21/202512.35 USD
12/19/202511.50 USD
12/18/202511.50 USD
12/17/202511.38 USD
12/16/202510.79 USD
12/15/202512.41 USD
12/14/202512.18 USD
12/12/202511.98 USD
12/11/202511.98 USD
12/10/202512.96 USD
12/9/202512.81 USD
12/8/202513.32 USD
12/7/202513.19 USD
12/5/202513.58 USD
12/4/202513.58 USD
12/3/202513.18 USD
12/2/202512.58 USD
12/1/202511.65 USD
11/30/202512.23 USD
11/28/202512.96 USD
11/27/202512.96 USD
11/26/202513.02 USD
11/25/202513.02 USD
11/24/202512.93 USD
11/23/202513.07 USD
11/21/202513.26 USD
11/20/202513.26 USD
11/19/202513.14 USD
11/18/202513.10 USD
11/17/202513.53 USD
11/16/202513.53 USD
11/14/202513.16 USD
11/13/202513.16 USD
11/12/202513.15 USD
11/11/202513.44 USD
11/10/202513.26 USD
11/9/202512.89 USD
11/7/202512.79 USD
11/6/202512.79 USD
11/5/202512.00 USD
11/4/202515.78 USD
11/3/202515.71 USD
11/2/202515.86 USD
10/31/202516.36 USD
10/30/202516.36 USD
10/29/202516.17 USD
10/28/202516.17 USD
10/27/202516.17 USD
10/26/202515.70 USD
10/23/202516.52 USD
10/22/202515.81 USD
10/21/202515.83 USD
10/20/202515.86 USD
10/19/202516.23 USD
10/16/202515.65 USD
10/15/202515.70 USD
10/14/202515.90 USD
10/13/202515.06 USD
10/12/202515.00 USD
10/9/202514.92 USD
10/8/202514.20 USD
10/7/202514.10 USD
10/6/202513.78 USD
10/5/202513.66 USD
10/2/202513.84 USD
10/1/202513.72 USD
9/30/202514.01 USD
9/29/202514.03 USD
9/28/202513.99 USD
9/25/202513.70 USD
9/24/202513.80 USD
9/23/202514.09 USD
9/22/202513.22 USD
9/21/202513.51 USD
9/18/202513.45 USD
9/17/202513.99 USD
9/16/202513.70 USD
9/15/202513.92 USD
9/14/202513.70 USD
9/11/202513.85 USD
9/10/202513.98 USD
9/9/202513.34 USD
9/8/202513.99 USD
9/7/202513.84 USD
9/4/202513.91 USD
9/3/202514.00 USD
9/2/202513.91 USD
9/1/202513.78 USD
8/28/202513.24 USD
8/27/202513.03 USD
8/26/202512.86 USD
8/25/202512.76 USD
8/24/202513.21 USD
8/21/202512.99 USD
8/20/202512.70 USD
8/19/202512.88 USD
8/18/202512.56 USD
8/17/202512.71 USD
8/14/202513.01 USD
8/13/202512.66 USD
8/12/202512.51 USD
8/11/202512.39 USD
8/10/202511.90 USD
8/7/202511.80 USD
8/6/202511.75 USD
8/5/202511.65 USD
Access this data via the Eulerpool API
Get Free API Key

Benitec Biopharma Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
80,000.00 USD
-19.08 M USD
-19.56 M USD
Jan 1, 2024
0.00 USD
-22.49 M USD
-22.37 M USD
Jan 1, 2025
0.00 USD
-41.77 M USD
-37.92 M USD
Jan 1, 2026 (e)
25.43 M USD
-5.09 M USD
-36.93 M USD
Jan 1, 2027 (e)
27.33 M USD
-5.46 M USD
-35.06 M USD
Jan 1, 2028 (e)
71.10 M USD
-14.22 M USD
-53.41 M USD
Jan 1, 2029 (e)
131.05 M USD
-26.21 M USD
-80.75 M USD
Jan 1, 2030 (e)
54.30 M USD
-10.86 M USD
-68.80 M USD

Benitec Biopharma Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 6, 2026, 1:23 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
2.002.008.003.0011.00––––––25.0027.0071.00131.0054.00
100.00–300.00-62.50266.67–––––––8.00162.9684.51-58.78
100.00100.00100.00100.00100.00––––––100.00100.00100.00100.00100.00
2.002.008.003.0011.0011.0011.0011.0011.0011.0011.0025.0027.0071.00131.0054.00
-9.00-16.00-4.00-9.002.00-8.00-13.00-17.00-19.00-22.00-41.00-5.00-5.00-14.00-26.00-10.00
-450.00-800.00-50.00-300.0018.18––––––-20.00-18.52-19.72-19.85-18.52
-9.00-18.00-4.00-9.002.00-8.00-13.00-18.00-19.00-22.00-37.00-36.00-35.00-53.00-80.00-68.00
50.00100.00-77.78125.00-122.22-500.0062.5038.465.5615.7968.18-2.70-2.7851.4350.94-15.00
6.868.456.888.2510.080.060.250.481.394.0636.2136.2136.2136.2136.2136.21
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Benitec Biopharma generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Benitec Biopharma retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Benitec Biopharma's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Benitec Biopharma has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Benitec Biopharma's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Benitec Biopharma stock margins

The Benitec Biopharma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Benitec Biopharma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Benitec Biopharma.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
-100.00 %
-22,666.67 %
-23,133.33 %
Jan 1, 2022
85.71 %
-25,500.00 %
-26,014.29 %
Jan 1, 2023
100.00 %
-23,850.00 %
-24,450.00 %
Jan 1, 2024
100.00 %
- %
- %
Jan 1, 2025
100.00 %
- %
- %
Jan 1, 2026 (e)
100.00 %
-20.00 %
-145.24 %
Jan 1, 2027 (e)
100.00 %
-20.00 %
-128.32 %
Jan 1, 2028 (e)
100.00 %
-20.00 %
-75.12 %

Benitec Biopharma Stock Revenue, EBIT, Earnings per Share

The Benitec Biopharma earnings per share therefore indicates how much revenue Benitec Biopharma has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
0.24 USD
-54.40 USD
-55.52 USD
Jan 1, 2022
0.15 USD
-37.19 USD
-37.94 USD
Jan 1, 2023
0.06 USD
-13.73 USD
-14.07 USD
Jan 1, 2024
0.00 USD
-5.54 USD
-5.51 USD
Jan 1, 2025
0.00 USD
-1.15 USD
-1.05 USD
Jan 1, 2026 (e)
0.70 USD
-0.14 USD
-1.02 USD
Jan 1, 2027 (e)
0.75 USD
-0.15 USD
-0.97 USD
Jan 1, 2028 (e)
1.96 USD
-0.39 USD
-1.48 USD

Benitec Biopharma business model & stock analysis

Benitec Biopharma Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Benitec Biopharma Employees
Details
Date
Benitec Biopharma Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Benitec Biopharma Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Benitec Biopharma historical P/E ratio, EBIT multiple, and P/S ratio

Benitec Biopharma annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Benitec Biopharma shares outstanding

The number of shares of Benitec Biopharma was 36.21 M in 2025. This indicates how many shares Benitec Biopharma is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
250,000.00 Stocks
Jan 1, 2022
480,000.00 Stocks
Jan 1, 2023
1.39 M Stocks
Jan 1, 2024
4.06 M Stocks
Jan 1, 2025
36.21 M Stocks
Jan 1, 2026 (e)
36.21 M Stocks
Jan 1, 2027 (e)
36.21 M Stocks
Jan 1, 2028 (e)
36.21 M Stocks

Benitec Biopharma stock splits

In Benitec Biopharma's history, there have been no stock splits.

Benitec Biopharma Dividend History

1 years of dividend payments

YearAnnual DividendYoY ChangePayments
20180.00USD—1×

Benitec Biopharma dividend payout ratio

In 2025, Benitec Biopharma had a payout ratio of 0.00%. The payout ratio indicates the percentage of the company's profits that Benitec Biopharma distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
0.00 %
Jan 1, 2022
0.00 %
Jan 1, 2023
0.00 %
Jan 1, 2024
0.00 %
Jan 1, 2025
0.00 %
Jan 1, 2026 (e)
0.00 %
Jan 1, 2027 (e)
0.00 %
Jan 1, 2028 (e)
0.00 %

Current Benitec Biopharma forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
92.31 % (12)
Hold
7.69 % (1)
Sell
0.00 % (0)
12M Price Target
24.48
Last Price
12.49
Currency
USD
12M Return Potential
96.00 %
LTM Return
0 %

Benitec Biopharma Analyst Rating Actions

DateFirmActionRatingReliability
3/9/2026
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
11/24/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
11/4/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
11/4/2025
Citizens
Citizens
MaintainedMarket Outperform–
9/24/2025
JMP Securities
JMP Securities
MaintainedMarket Outperform–
9/16/2025
Oppenheimer
Oppenheimer
MaintainedOutperform65
5/19/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
5/15/2025
JMP Securities
JMP Securities
MaintainedMarket Outperform–
4/10/2025
JMP Securities
JMP Securities
MaintainedMarket Outperform–
3/24/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Benitec Biopharma Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
5/12/2026-0.28USD-0.00USD-2026 Q3
2/12/2026-0.23USD-0.00USD-2026 Q2
11/14/2025-0.38USD-0.00USD-2026 Q1
11/11/2024-0.56USD-0.00USD-2025 Q1
5/13/2024-0.43USD-0.00USD-2024 Q3
2/12/2024-0.40USD-0.00USD-2024 Q2
5/15/2023-0.14USD-9,642.00USD-2023 Q3
2/13/2023-0.15USD-9,642.00USD-2023 Q2
11/10/2022-0.19USD-9,642.00USD-2023 Q1
9/2/2022-0.29USD-0.00USD-2022 Q4

Benitec Biopharma shareholder structure

% Name
31.89333%
Suvretta Capital Management, LLC
Suvretta Capital Management, LLC
8.04127%
Janus Henderson Investors
Janus Henderson Investors
6.06834%
Franklin Advisers, Inc.
Franklin Advisers, Inc.
5.85671%
Adage Capital Management, L.P.
Adage Capital Management, L.P.
5.10918%
RA Capital Management, LP
RA Capital Management, LP
3.24435%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
...

Benitec Biopharma Beneficial Ownership Filings (SEC 13D/G)

Free Float
97.5%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
49.90%
Aaron Cowen
Aaron Cowen
SEC ↗
44.47%
Averill Master Fund, Ltd.
Averill Master Fund, Ltd.
SEC ↗
44.10%
SUVRETTA CAPITAL MANAGEMENT, LLC
SUVRETTA CAPITAL MANAGEMENT, LLC
SEC ↗
14.00%
SCHEDULE 13D
SCHEDULE 13D
SEC ↗
10.60%
Franklin Resources, Inc.
Franklin Resources, Inc.
SEC ↗
9.99%
JANUS HENDERSON GROUP PLC
JANUS HENDERSON GROUP PLC
SEC ↗
9.90%
EIN #00-0000000
EIN #00-0000000
SEC ↗
8.89%
Steven M. Oliveira
Steven M. Oliveira
SEC ↗
8.70%
00-0000000
00-0000000
SEC ↗
8.39%
Nemean Asset Management, LLC
Nemean Asset Management, LLC
SEC ↗

Benitec Biopharma Executives and Management Board

9 members · avg. age 57 · 44 % women

JB

Dr. Jerel Banks (50)

Executive Chairman of the Board, Chief Executive Officer · since 2016

25.87 M USD

Management

MB

Ms. Megan Boston (53)

Chief Financial Officer, Executive Director, Secretary · since 2018

8.60 M USD
SM

Ms. Sophie Mukadam (44)

Chief Operating Officer

3.78 M USD
IK

Ms. Irina Koffler

Managing Director · since 2023

–

Board of Directors

JB

Mr. J. Kevin Buchi (70)

Independent Director

432,410.00 USD
PF

Mr. Peter Francis (69)

Independent Director

426,993.00 USD
ES

Mr. Edward Smith (54)

Independent Director

424,910.00 USD
KM

Mr. Kishan Mehta (40)

Independent Director

368,410.00 USD
SM

Dr. Sharon Mates (72)

Independent Director

–

Benitec Biopharma Supply Chain

Benitec Biopharma Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
3 companies
#NameTrend
1
Sio Gene Therapies
Customer·Biotechnology·US
-0.73
0.20
0.93
0.83
0.95
0.65
#NameTrend
1
4D Molecular Therapeutics
Supplier·Biotechnology·US
0.64
0.95
0.92
0.87
0.89
—
2
Alnylam Pharmaceuticals
Supplier·Customer·Biotechnology·US
-0.13
0.74
0.93
0.60
0.76
-0.08

Frequently asked questions about Benitec Biopharma

Analysts currently set an average price target of 25.70 USD for the Benitec Biopharma stock (median: 24.48 USD), implying +105.8 % versus the latest price. The consensus is based on 13 analyst ratings.

Benitec Biopharma Analyst Price Targets 2026

13 analysts currently rate the Benitec Biopharma stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Benitec Biopharma to generate revenue of 25.43 M USD and earnings per share of -1.02 USD.

Benitec Biopharma Analyst Price Targets 2026

Converted at the current exchange rate, the Benitec Biopharma share trades at 10.16 EUR (11.71 USD).

The Benitec Biopharma share (BNTC) is listed on 3 stock exchanges, including: NASDAQ (BNTC), Frankfurt (BJ93.F), München (BJ93.MU).

No history available for Benitec Biopharma.

The expected revenue of Benitec Biopharma is 25.43 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Benitec Biopharma is -36.93 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Benitec Biopharma is currently -11.48. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Benitec Biopharma stock.

The price-to-sales ratio (P/S) of Benitec Biopharma is currently 16.67. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Benitec Biopharma stock.

The Eulerpool Quality Score for Benitec Biopharma is 1/10.

The ISIN of Benitec Biopharma is US08205P2092. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Benitec Biopharma is 722783. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Benitec Biopharma is BNTC. The ticker symbol is used to trade Benitec Biopharma shares on the stock exchange.

The current dividend yield of Benitec Biopharma is 0.03 %.

Benitec Biopharma paid dividends every year for the past 0 years.

Benitec Biopharma is assigned to the 'Health' sector.

To receive the latest dividend of Benitec Biopharma from amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Benitec Biopharma are distributed in USD.

All fundamentals and in-depth analysis of Benitec Biopharma

Our stock analysis for Benitec Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Benitec Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Benitec Biopharma Stock
Benitec Biopharma Revenue→
Benitec Biopharma Stock
Benitec Biopharma Net Income→
Benitec Biopharma Stock
Benitec Biopharma P/E→
Benitec Biopharma Stock
Benitec Biopharma P/S→
Benitec Biopharma Stock
Benitec Biopharma EBIT→
Benitec Biopharma Stock
Benitec Biopharma Dividend→
Benitec Biopharma Stock
Benitec Biopharma Directors Dealings→
Benitec Biopharma Stock
Benitec Biopharma Stocks→
Benitec Biopharma Stock
Benitec Biopharma Market capitalization→
Benitec Biopharma Stock
Benitec Biopharma Debt→
Benitec Biopharma Stock
Benitec Biopharma Liabilities→
Benitec Biopharma Stock
Benitec Biopharma Equity→
Benitec Biopharma Stock
Benitec Biopharma AAQS→
Benitec Biopharma Stock
Benitec Biopharma Employees→
Benitec Biopharma Stock
Benitec Biopharma ROE→
Benitec Biopharma Stock
Benitec Biopharma ROA→
Benitec Biopharma Stock
Benitec Biopharma ROCE→
Benitec Biopharma Stock
Benitec Biopharma News→
Benitec Biopharma Stock
Benitec Biopharma Analyst Price Targets→

Health Stocks

BenQ Medical TechnologyBen Tre Pharmaceutical JSCBeOne MedicinesBelite Bio Inc ADRBerry Genomics CoBeijing Wantai Biological Pharmacy Enterprise CoBeryl DrugsBeijing Wandong Medical Technology CoBespoke ExtractsBeijing Tong Ren Tang CoBeta BionicsBeijing Tong Ren Tang Chinese Medicine CoAll Stocks A–Z →